首页> 外文OA文献 >Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer

【2h】

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer

机译：异常表达和效力作为前列腺癌中α-甲基酰基辅酶A消旋酶的癌症免疫治疗靶标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ichiya Honma; Toshihiko Torigoe; Yoshihiko Hirohashi; Hiroshi Kitamura; Eiji Sato; Naoya Masumori; Yasuaki Tamura; Taiji Tsukamoto; Noriyuki Sato;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer [J] . Ichiya Honma, Toshihiko Torigoe, Yoshihiko Hirohashi, Journal of Translational Medicine . 2009,第1期

机译：异常表达和效力作为前列腺癌中α-甲基酰基辅酶A消旋酶的癌症免疫治疗靶标
2. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions. [J] . Zielie PJ, Mobley JA, Ebb RG, The Journal of Urology . 2004,第3期

机译：确定前列腺分泌物中的消旋酶α-甲基酰基辅酶是一种针对前列腺癌的新颖诊断方法。
3. Relationship between alpha-methylacyl-coenzyme A racemase expression and mucin phenotype in gastric cancer [J] . NozawaY., NishikuraK., AjiokaY., Human Pathology . 2012,第6期

机译：胃癌中α-甲基酰基辅酶A消旋酶表达与粘蛋白表型的关系
4. Chemically Self-Assembled Nanorings (CSANs) for Prostate Cancer Targeted Immunotherapy [C] . Sidath C. Kumarapperuma, Alexer R. Hendricks, Jacob Petersburg, PEGS . 2015

机译：用于前列腺癌靶向免疫疗法的化学自组装纳米 - 肿瘤（CSANs）
5. Targeting a self/tumor antigen expressed in the prostate for adoptive T cell immunotherapy of prostate cancer. [D] . Chou, Cassie K. 2012

机译：靶向前列腺中表达的自身/肿瘤抗原，用于前列腺癌的过继T细胞免疫疗法。
6. Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer [O] . Ichiya Honma, Toshihiko Torigoe, Yoshihiko Hirohashi, 2009

机译：异常表达和效力作为前列腺癌中α-甲基酰基辅酶A消旋酶的癌症免疫治疗靶标
7. Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer [O] . Honma, Ichiya, Torigoe, Toshihiko, Hirohashi, Yoshihiko, 2009

机译：异常表达和效力作为前列腺癌中α-甲基酰基辅酶A消旋酶的癌症免疫治疗靶标
8. Prostate Cancer Immunotherapy by Targeting Dendritic Cells In Vivo Using Receptor-Specific Aptamer Conjugated to Prostate Stem Cell Antigen (PSCA)- Encoding RNA [R] . Nair, S. 2011

机译：使用与前列腺干细胞抗原（psCa）共轭的受体特异性适体在体内靶向树突细胞的前列腺癌免疫疗法 - 编码RNa

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer

著录项

引文网络

相似文献

相关主题

期刊订阅